T1	Participants 48 73	congestive heart failure.
T2	Participants 231 289	patients with moderate to severe congestive heart failure.
T3	Participants 290 350	Seventeen patients on chronic digitalis and diuretic therapy
T4	Participants 702 730	flosequinan-treated patients
T5	Participants 1147 1202	patients with moderate to severe chronic heart failure.
